HCC
FBIO icon

Hirtle Callaghan & Co’s Fortress Biotech FBIO Stock Holding History

Hirtle Callaghan & Co’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-138
Closed -$5K – 142
2014
Q4 		$5K Hold
138
– – ﹤0.01% 462
2014
Q3 		$4K Hold
138
– – ﹤0.01% 512
2014
Q2 		$4K Hold
138
– – ﹤0.01% 546
2014
Q1 		$4K Hold
138
– – ﹤0.01% 534
2013
Q4 		$5K Hold
138
– – ﹤0.01% 503
2013
Q3 		$14K Hold
138
– – ﹤0.01% 455
2013
Q2 		$18K Buy
+138
New +$20.3K 0.21% 44

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return